Select language :
According to the recent 2021 European Society of Cardiology (ESC) Guidelines on cardiovascular disease prevention in clinical practice, the importance of atherosclerosis cardiovascular (CV) disease prevention remains undisputed and should be delivered:
Personalized patient communication is crucial. Individualized cardiovascular risk assessment supports clinical decision-making and patient engagement, helping set personalized health goals.
This tool also illustrates the impact of poor lipid control-often due to non-adherence to medication or unhealthy lifestyle choices – empowering patients to make informed changes.2
This user-friendly calculator, based on the latest ESC guidelines, is suitable for all patients, including those at very high risk. It integrates Non-HDLc values into the Systemic Cornoary Risk Estimation 2 (SCORE23) and SCORE2-Older Persons (SCORE2-OP4) algorithms, offering healthcare professionals clear recommendations for LDL-c and non-HDLe targets consistent with ESC/EAS guidelines.